SETDB1在卵巢癌中的表达及临床意义
投稿时间:2016-03-02  修订日期:2016-03-11  点此下载全文
引用本文:董红玲.SETDB1在卵巢癌中的表达及临床意义[J].医学研究杂志,2017,46(3):145-148,152
DOI: 10.11969/j.issn.1673-548X.2017.03.036
摘要点击次数: 946
全文下载次数: 696
作者单位
董红玲 430015 武汉, 江汉大学附属医院妇产科 
中文摘要:目的 研究SET结构域分支型1(SET domain bifurcated 1,SETDB1)在人卵巢癌中的表达情况以及对患者预后的影响。方法 收集2010年1月~2012年12月间于笔者医院妇产科行手术切除的卵巢癌及对应癌旁组织共44例,运用qRT-PCR技术检测SETDB1 mRNA在卵巢癌及对应癌旁组织中的表达水平,免疫组化染色检测SETDB1蛋白的表达情况,通过卡方检验分析SETDB1蛋白表达与患者临床病理资料间的相关性,采用Kaplan-Meier生存曲线分析SETDB1蛋白表达水平对患者3年生存预后的影响。结果 卵巢癌组织中SETDB1显著高表达(P<0.05);卵巢癌组织 SETDB1蛋白阳性表达与淋巴结转移(P<0.05)及较晚的FIGO分期(Ⅲ+Ⅳ,P<0.05)具有显著的相关性;与SETDB1蛋白表达阴性患者相比,SETDB1蛋白阳性表达的患者3年总生存率及无病生存率均显著降低(P<0.05)。结论 卵巢癌中SETDB1表达水平异常升高并与患者不良预后密切相关,SETDB1对卵巢癌患者可能具有一定的预后评价作用。
中文关键词:SETDB1  卵巢癌  表达  临床意义
 
Expression and Clinical Significance of SETDB1 in Human Ovarian Carcinoma
Abstract:Objective To investigate the expression and clinical significance of SETDB1 in human ovarian carcinoma. Methods 44 ovarian carcinoma tissues and matched tumor-adjacent tissues were collected from January, 2010 to December, 2012. The mRNA expression of SETDB1 was detected by qRT-PCR, and the protein expression of SETDB1 was detected by immunohistochemistry. The correlation between SETDB1 and clinic pathological features was analyzed by chi-square test, and the Kaplan-Meier survival curves were drawn to describe the prognostic effects of SETDB1 expression. Results The expression of SETDB1 was up-regulated in ovarian carcinoma tissues compared to those matched tumor-adjacent tissues(P<0.05). Positive expression of SETDB1 was associated with lymphatic metastasis (P<0.05) and advanced FIGO stage (Ⅲ+Ⅳ, P<0.05). Both the 3-year overall survival rate and tumor-free survival rate were lower in SETDB1 positive expression group than SETDB1 negative expression group (P<0.05). Conclusion Positive expression of SETDB1 in human ovarian carcinoma is related to the poor prognosis. SETDB1 has a potential to predict the prognosis for ovarian carcinoma patients.
keywords:SETDB1  Ovarian carcinoma  Expression  Clinical significance
查看全文  查看/发表评论  下载PDF阅读器

京公网安备 11010502037822号